Feb 27, 2020
Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020
Feb 21, 2020
Special Learning, Inc. Joins a California Grant Consortium to Help Individuals Obtain Education and Find Employment Opportunities in the Autism and Special Needs Field
Feb 13, 2020
Global Epidemiology Forecast for Diabetic Peripheral Neuropathy (DPN) to 2030
Feb 13, 2020
RegeneRx Partner Receives Canadian Patent For Treatment of Peripheral Neuropathy
Feb 12, 2020
Global Bell's Palsy Incidence Assessment by Ethnicity & Geography, 2019-2029
Feb 12, 2020
Checkpoint Surgical Devices Are Key Component In New Surgical Procedure Providing Relief For Amputees Suffering With Limb Pain
Feb 11, 2020
Global Market Study of Neuropathic Pain Management: Rise in Number of Pain Management Centers and Availability of Approved Drugs Shaping the Future
Feb 06, 2020
Newport Beach Institute Launches Home-Based Vestibular Virtual Reality System Used to Treat Mark Cuban for Dizziness
Feb 06, 2020
NeuroSense Therapeutics Receives Orphan Drug Designation for Amyotrophic Lateral Sclerosis (ALS) Drug, and Announces Initiation of Two Clinical Studies in ALS
Feb 06, 2020
AFTD Welcomes Rosa Canet-Avilés, Ph.D., as Senior Director of Scientific Initiatives
Feb 04, 2020
New State-of-the-Art Arizona Pain Center Opened February 3, 2020
Jan 29, 2020
Southwest Florida Free Pain Clinic Honored by ICON Impact Award Nomination
Jan 28, 2020
Harvard Professor Francisco Quintana Wins 2019 Barancik Prize for Innovation in MS Research
Jan 27, 2020
Dr. Ioannis Skaribas, M.D., FASA, DABA Performs the First Abbott Proclaim XR(TM) Spinal Cord Stimulator Procedure in Houston, TX
Jan 24, 2020
Dr. Seth Resnick, AdvantageCare Physicians' Chair of Psychiatry, Named Distinguished Fellow by American Psychiatric Association
Jan 24, 2020
Clene Nanomedicine Announces Formal Acceptance of CNM-Au8 for HEALEY ALS Platform Trial as Center Receives FDA Approval to Proceed
Jan 22, 2020
Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General
Jan 22, 2020
Nevro to Present New Clinical Evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting
Jan 21, 2020
Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
Jan 14, 2020
ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial